Hypogonadism and Testosterone Replacement Therapy: Pharmacist
|
|
- Noel Rose
- 5 years ago
- Views:
Transcription
1 Hypogonadism and Testosterone Replacement Therapy: Practical Insights for the Pharmacist Roger G. Hefflinger, PharmD Associate Professor of Pharmacy Practice and Administrative Services Idaho State University, College of Pharmacy Pocatello, Idaho Faculty Information Presenter: Roger G. Hefflinger, PharmD Associate Professor of Pharmacy Practice and Administrative Services Idaho State University, College of Pharmacy Pocatello, Idaho Moderator: Jeff D. Prescott, PharmD, RPh Vice President, Clinical Affairs Pharmacy Times This activity is supported by an educational grant from Abbott Laboratories. 2 1
2 Disclosures Roger G. Hefflinger, PharmD, has no relevant financial relationships to disclose. The planning staff from the Pharmacy Times Office of Continuing Professional Education have no relevant financial relationships to disclose. The contents of this webinar may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products. 3 Educational Objectives At the conclusion of this program, participants should be able to: Review the prevalence, epidemiology, and pathophysiology of testosterone deficiency Recognize the signs and symptoms related to hypogonadism, as well as causative factors, including medications Evaluate the available and emerging testosterone replacement therapies and examine their risks and benefits Counsel patients on the correct usage of the various testosterone dosage forms in order to improve patient adherence and outcomes 4 2
3 Pharmacy Accreditation Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation ti Council ilfor Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1 contact hour (0.1 CEU) under the ACPE universal program number H01 P. This program is available for CE credit through September 15, Type of Activity: Knowledge based. 5 Hypogonadism and Testosterone Replacement Therapy: Practical Insights for the Pharmacist Roger G. Hefflinger, PharmD Associate Professor of Pharmacy Practice and Administrative Services Idaho State University, College of Pharmacy Pocatello, Idaho 3
4 Origination of Testicular Dysfunction Male hypogonadism Fetal hypogonadism Pubertal hypogonadism Adult hypogonadism hypogonadism/ds Signs and Symptoms of Hypogonadism Birth and infancy: early signs Failure of the testes to descend Normally formed dhypotrophic hi penis Adolescent males Delayed, arrested, or absent testicular growth Delayed secondary sex characteristics Hi Hair Acne Muscle mass Vocal cord development voice changes hypogonadism/ds
5 Signs and Symptoms of Hypogonadism In adult males: Psychological symptoms Sad, down, loss of energy, tired, fatigued? Physical symptoms Health limited vigorous activity, walking <1 km, limited bending, kneeling, stooping? Sexual symptoms Awaken with morning erection, erection sufficient for sexual activity, frequency of thoughts of sex? 1. hypogonadism/ds00300; 2. Wu et al. N Engl J Med. 2010;363(2): ; 3. Trinick TR et al. Aging Male. 2011;14(1):10 15; Incidence Estimated that there is a decline in net testosterone of 0.4% to 0.7% a year above age 40 Total T Free T Albumin bound T Sex Hormone Binding Globulin (SHBG) 20% of men >60 years old 30% to 40% of men >80 years old Serum testosterone levels l lower than younger adult males 1. Feldman HA et al. J Clin Endo Metab. 2002;87: ; 2. Faiman C. Male hypogonadism. In: Cleveland Clinic Current Clinical Medicine 2nd ed
6 Incidence/Prevalence Difficult for clinicians and researchers to come to consensus Survey of 3369 males, 40 to 79 years of age Questionnaires; measurement of morning total testosterone, free testosterone International Web survey shows high prevalence ofsymptomatic testosterone deficiency in men 1. Wu et al. N Engl J Med. 2010;363(2): ; 2. Trinick TR et al. Aging Male. 2011;14(1): Nomenclature Primary Primary testicular failure Undescended testicles Mumps Injury Hemachromatosis Klinefelter syndrome Secondary Problem originates in the hypothalamus or the pituitary gland Pituitary tumors Obesity HIV/AIDS Medications Inflammatory diseases Kallmann syndrome Normal aging UpToDate Causes of Primary Hypogonadism. 12 6
7 Late Onset Hypogonadism Androgen Decline in the Aging Male (ADAM) Partial Androgen Deficiency of the Aging Male (PADAM) Andropause Male Climacteric Testosterone Deficiency Syndrome All are representative names for the symptoms that correlate with declining testosterone levels ISSAM Standards and Guidelines. Aging Male. 2002;5: Testosterone Levels Throughout Life In utero: first trimester Fetal testes secrete T Stimulated by placental gonadotropins Second trimester Same as mid puberty Falls and then rises at birth Infancy Fll Falls, rises, falls fll Significance unknown Puberty Peaks 500 to 700 ng/dl Brunton LL et al. Goodman & Gilman s The Pharmacological Basis of Therapeutics. 11th ed
8 Puberty/Control of Testicular Function Hypothalamus synthesizes: Gonadotropin releasing hormone (GnRH) GnRH pulses every 30 to 120 minutes Anterior pituitary Responds to GnRH and releases leutinizing hormone (LH) and folliclestimulating hormone Leydig cells of the testes Testosterone 95% Dihydrotestosterone <20% Estradiol <20% Estrone <2% DHEA <10% Brunton LL et al. Goodman & Gilman s The Pharmacological Basis of Therapeutics. 11th ed Actions of Testosterone Testosterone Dihydrotestosterone Estradiol Androgen Receptor Androgen Receptor Estrogen Receptor External genitalia: Differentiation during gestation Maturation during puberty Adulthood prostatic diseases Hair follicles: Increased growth during puberty Internal genitalia: Wolffian development during gestation Skeletal muscle: Increase mass and strength during puberty Erythropoiesis Bone? Bone: Epiphyseal closure and increased density Libido? Brunton LL et al. Goodman & Gilman s The Pharmacological Basis of Therapeutics. 11th ed
9 Effects of Androgens on Tissues Skeletal muscles Skin Hair Male pattern baldness CNS Mood Energy Motivation Aggression Bone marrow Testes Libido Prostate tissue 1. Brunton LL et al. Goodman & Gilman s The Pharmacological Basis of Therapeutics. 1th ed UpToDate Causes of Primary Hypogonadism. 17 Correlations of Low Testosterone Obesity Osteoporosis Mtbli Metabolic syndrome Diabetes Cardiovascular disease Alzheimer s disease Depression Frailty Premature Death Fatigue Erectile dysfunction Decreased sex drive Difficulty concentrating Hot flushes Muscle weakness 1. Trinick TR et al. Aging Male. 2011;14(1):10 15; 2. UpToDate Causes of Primary Hypogonadism; 3. hypogonadism/ds
10 Data to Show Beneficial Outcomes Reduced cardiovascular risk? Increased cardiovascular risk? 19 Patients to be Considered for Replacement Therapy Positive questionnaire Aging Males Symptom Scale AMS 36 Item Short Form Health Survey (SF 36) Low to lower testosterone levels 20 10
11 International Society for the Study of Aging Males Aging Males Symptoms (AMS) Scale 21 The International Society for the Study of the Aging Male Easily recognized features of diminished sexual desire and erectile quality, particularly nocturnal erections Changes in mood with concomitant decreases in intellectual activity, spatial orientation ability, fatigue, depressed mood, and irritability Decrease in lean body mass with associated decreased muscle mass and strength Decrease in body hair and skin alterations Decrease in bone mineral density resulting in osteopenia and osteoporosis Increased visceral fat Morales A et al. Aging Male. 2002;5:
12 Other Related Factors Recent weight gain (29%) Alcohol (17.3%) Testicular problems and orchitis (11.4%) Prostate operations and infections (5.6%) Urinary Infections (5.2%) Diabetes (5.7%) Medications: Methadone Opiates Buprenorphine Glucocorticoids Ketoconazole Chemotherapy Alkylating agents Cisplatin 1. Trinick TR et al. Aging Male. 2011;14(1):10 15; 2. UpToDate Causes of Primary Hypogonadism; 3. hypogonadism/ds Androgen Replacement Therapy (ART) Testosterone Rapid first pass 17α alkylated androgens Methytestosterone Winstrol (stanozolol) Testosterone esters Testosterone enanthate Testosterone cypionate Adapted from Brunton LL et al. Good & Gilman s The Pharmacological Basis of Therapeutics. 11th ed
13 ART (cont.) Transdermal patches Serum level fluctuates; peaks 6 to 9 hours; drops until next patch Testosterone gels Mean testosterone levels relatively constant between each application Testosterone buccal Testosterone implant Testosterone solution Testosterone cream Testosterone ointment IM enanthate or cypionate Administered every 2 to 4 weeks may be supratherapeutic and then drop Blood level at the mid injection interval should ldbe normal and dosage and interval adjusted accordingly 25 Adverse Effects of Androgens Hypogonadal men who undergo replacement may experience similar effects to testosterone surges in puberty Acne Gynecomastia More aggressive sexual behavior Mineral Corticoid Effects Sodium and water retention CHF, HTN, CAD Erythropoesis Stimulation Increase hemoglobin, hematocrit (sudden death in abuse?) Adapted from Brunton LL et al. Good & Gilman s The Pharmacological Basis of Therapeutics. 11th ed
14 ART Adverse Drug Reactions Monitoring Parameters Prostate Enlargement Alterations urine Increase risk CA PSA Baseline Periodically 18% of patients had increase over 42 months Most within first year Hemoglobin Hematocrit Periodically Lipids Periodically Transaminitis AST/ALT Periodically AndroGel (testosterone gel) 1% [prescribing information]; Fortesta (testosterone) Gel [prescribing information]; Testim 1% (testosterone gel) [prescribing information]. 27 Boxed Warnings Virilization has been reported in children who have been secondarily exposed to topical testosterone products Children should avoid contact with unwashed or unclothed application sites of patients using topical testosterone Health care providers should advise patients to strictly adhere to instructions for use AndroGel (testosterone gel) 1% [prescribing information]; Fortesta (testosterone) Gel [prescribing information]; Testim 1% (testosterone gel) [prescribing information]
15 Contraindications to Testosterone Men with carcinoma of the breast or known orsuspected prostate cancer Pregnant or breast feeding women. Testosterone may cause fetal harm AndroGel (testosterone gel) 1% [prescribing information]; Fortesta (testosterone) Gel [prescribing information]; Testim 1% (testosterone gel) [prescribing information]. 29 Cautions Patients with benign prostatic hyperplasia (BPH) treated with androgens are at an increased risk for worsening of signs and symptoms of BPH Secondary exposure to testosterone in children and women can occur with use of testosterone gel. Cases of secondary exposure resulting in virilization ili of children have been reported AndroGel (testosterone gel) 1% [prescribing information]; Fortesta (testosterone) Gel [prescribing information]; Testim 1% (testosterone gel) [prescribing information]
16 Cautions (cont.) Exogenous testosterone administration may lead to azospermia Edema with or without congestive heart failure may be a complication in patients with preexisting heart, renal, or hepatic disease Exacerbation of sleep apnea may occur, especially in patients with obesity and chronic lung disease AndroGel (testosterone gel) 1% [prescribing information]; Fortesta (testosterone) Gel [prescribing information]; Testim 1% (testosterone gel) [prescribing information]. 31 General Application Education Children and women should avoid contact with unwashed or unclothed application site(s) in men using testosterone gel To minimize the potential for transfer to others, patients using topical testosterone should apply the product as directed dand strictly adhere to the following: AndroGel (testosterone gel) 1% [prescribing information]; Fortesta (testosterone) Gel [prescribing information]; Testim 1% (testosterone gel) [prescribing information]
17 Topical Education (cont.) Wash hands with soap and water after application Cover the application site with clothing after the gel has dried Wash the application site thoroughly with soap and water prior to any situation where skin toskin contact of the application site with another person is anticipated AndroGel [prescribing information]; Fortesta [prescribing information]; Testim [prescribing information]. 33 Common Sense Counseling Avoid fire, flames, or smoking until the gel has dried, since alcohol based products are flammable AndroGel (testosterone gel) 1% [prescribing information]; Fortesta (testosterone) Gel [prescribing information]; Testim 1% (testosterone gel) [prescribing information]
18 Transdermal Testosterone Gels AndroGel (testosterone gel) 1% 25 mg/2.5 g 50 mg/5 g AndroGel (testosterone gel) Pump 1.25 g/pump 2 to 4 pumps per day AndroGel (testosterone gel) 1.62% mg/actuation 40.5 mg 2 pumps to start Fortesta (testosterone) Gel 10 mg/actuation 4 actuations, 40 mg Testim 1% (testosterone gel) 50 mg/5 g tube AndroGel (testosterone gel) 1% [prescribing information]; Fortesta [prescribing information]; Testim [prescribing information]. 35 Dosage Adjustment: Older 1% Gels AndroGel Serum testosterone levels should ldbe measured at intervals If the levels are below normal, the dose may be increased to 5 to 7.5 g, 7.5 to 10 g If the serum level lis consistently above normal at a dose of 5 g, should discontinue Testim Morning serum testosterone measured 14 days after starting Increase if below normal ranges; to 10 g (2 tubes) AndroGel (testosterone gel) 1%)[prescribing information]
19 Dosage Adjustment: AndroGel 1.62% mg/actuation 2 pumps to start Around days 14 and 35 Pre dose morning blood T level Pre Dose Monitoring Total Serum Testosterone Concentration >750 ng/dl 350 and 750 ng/dl <350 ng/dl Dose Titration Decrease daily dose by mg (1 pump actutation) No change; continue on current dose Increase daily dose by mg (1 pump actutation) AndroGel (testosterone gel) 1.62%) [prescribing information]. 37 Dosage Adjustment: Fortesta Normal starting dose: 4 pumps (40 mg) 2 hours after application: On days 14, 35 Total Serum Testosterone Concentration 2 hours Post Fortesta Application >2500 ng/dl 1250 and <2500 ng/dl 500 and <1250 ng/dl <350 ng/dl Dose Titration Decrease daily dose by 20 mg (2 pump actuations) Decrease daily dose by 10 mg (1 pump actuation) No change; continue on current dose Increase daily dose by 10 mg (1 pump actuation) Fortesta (testosterone) Gel [prescribing information]
20 Transdermal Testosterone Solution Axiron Underarm applicator Blood level T 14 days after initiation 1050 Daily Prescribed Dose # of Pump Actuations 2 to 8 hours after application Dosage adjustment: 300 to 1050 Application instructions Application 30 mg 1 (once daily) Apply once to 1 axilla only (left or right) 60 mg 2 (once daily) 90 mg 3 (once daily) 120 mg 4 (once daily) Apply once to the left axilla and then apply once to right axilla Apply once to the left and once to the right axilla, wait for the product to dry, and then apply once again to the left OR right axilla Apply once to the left and once to the right axilla, wait for the product to dry, and then apply once again to the left AND right axilla Axiron (testosterone topical solution) 1% [prescribing information]. 39 Transdermal Testosterone Cream/Ointment Cream First Testosterone t t MC 48 g moisturizing cream 12 ml T (100 mg/ml) When mixed, 2% cream Stable at room temperature for 6 months 5 ml rubbed onto shoulders once daily Ointment First Testosterone t t 48 g petrolatum 12 ml T (100 mg/ml) When mixed, 2% ointment Stable at room temperature for 6 months 5 ml rubbed onto shoulders once daily First Testosterone MC 2% [prescribing information]
21 Striant Transmucosal Buccal 30 mg buccal system Twice daily dosing Serum concentrations rise for 10 hours Study 1 Study 2 12 weeks (N = 82) 7 days (N = 29) C avg(0 24) (ng/dl) 520 (± 205) 550 (± 169) C max(0 24) (ng/dl) 970 (± 442) 910 (± 319) C min(0 24) (ng/dl) 290 (± 130) 320 (± 131) Striant (testosterone buccal system) [prescribing information]. 41 Intramuscular Testosterone Cypionate Depo Testosterone 100, 200 mg/ml In oil base Normal for discoloration 100 to 400 mg IM every 2 to 4 weeks Enanthate Delatestryl 200 mg/ml Accessed August 8,
22 Transdermal Testosterone Patchs Androderm 2.5 mg/24 hours 5 mg/24 hours Mean steady state levels 29 men used 2.5 mg patches 27 used 2 systems (5 mg) 2 used 3 systems (7.5 mg) Androderm (testosterone transdermal system) [prescribing information]. 43 Role of the Pharmacist Patient advocacy for candidate males Depression medications Increased appearance of obesity Flat affect at consultation Prescriptions/samples for ED medications Physician education for the symptoms Diabetes CAD HTN Depression 44 22
23 Role of the Pharmacist Monitoring for interacting medications Drug induced hypogonadism ethanol, opiates, methadone, ketoconazole Drug interactions with testosterone replacement We induced a problem prostate Alpha 1 antagonists Selective, Not 5 alpha reductase inhibitors We induced a problem with hairline Corticosteroid coadministration 45 Role of the Pharmacist Cost coverage issues AndroGel Restoration Program Axiron Promise Program Testim Savings Voucher Program 46 23
24 Role of the Pharmacist Counseling Avoiding secondary exposure Apply to upper chest and shoulders, cover with shirt Appropriate application Daily adherence Do not self escalate dosage 47 Hypogonadism and Testosterone Replacement Therapy: Practical Insights for the Pharmacist THANK YOU! For any questions regarding this activity, contact: 24
Hypogonadism 4/27/2018. Male Hypogonadism -- Definition. Epidemiology. Objectives HYPOGONADISM. Men with Hypogonadism. 95% untreated.
Male Hypogonadism -- Definition - Low T, Low Testosterone Hypogonadism -...a clinical syndrome that results from failure of the testes to produce physiological concentrations of testosterone due to pathology
More informationAndroderm patch, AndroGel packets and pump, Axiron solution, First- Testosterone, First-Testosterone MC, Fortesta gel, Testim gel, Vogelxo
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.31 Subject: Testosterone Topical Page: 1 of 9 Last Review Date: September 23, 2016 Testosterone topical
More informationEvaluation and Treatment of Primary Androgen Deficiency Syndrome in Male Patients
Evaluation and Treatment of Primary Androgen Deficiency Syndrome in Male Patients Jeff Unger, MD Director Chino Medical Group Diabetes and Headache Intervention Center Chino, California January 16, 2008
More informationTESTOSTERONE DEFINITION
DEFINITION A hormone that is a hydroxyl steroid ketone (C19H28O2) produced especially by the testes or made synthetically and that is responsible for inducing and maintaining male secondary sex characteristics.
More informationGUIDELINES ON. Introduction. G.R. Dohle, S. Arver, C. Bettocchi, S. Kliesch, M. Punab, W. de Ronde
GUIDELINES ON Male Hypogonadism G.R. Dohle, S. Arver,. Bettocchi, S. Kliesch, M. Punab, W. de Ronde Introduction Male hypogonadism is a clinical syndrome caused by androgen deficiency. It may adversely
More informationGA KS KY LA MD NJ NV NY TN TX WA Applicable X X N/A N/A X N/A X X X X X X N/A N/A NA *FHK- Florida Healthy Kids. Androgens
Androgens Override(s) Prior Authorization Quantity Limit Approval Duration Varies upon diagnosis Medication Strengths Quantity Limit Comments Generic Androgel 1% (2.5 g) packet 2 packets per day (testosterone
More information6/14/2010. GnRH=Gonadotropin-Releasing Hormone.
Male Androgen Replacement Mitchell Sorsby, MD June 19, 2010. QUESTION # 1 Which of the following is not a symptom associated with low T levels? a) decreased libido b) erectile dysfunction c) depression
More informationMale Hypogonadism. Types and causes of hypogonadism. What is male hypogonadism? Symptoms. Testosterone production. Patient Information.
Patient Information English 31 Male Hypogonadism The underlined terms are listed in the glossary. What is male hypogonadism? Male hypogonadism means the testicles do not produce enough of the male sex
More informationAndrogens. Medication Strengths Quantity Limit Comments Androderm (testosterone patch) 1% pump 2 pump bottles per Non-Preferred
Market DC Androgens Override(s) Prior Authorization Quantity Limit Approval Duration Varies upon diagnosis Medication Strengths Quantity Limit Comments Androderm (testosterone patch) AndroGel (testosterone
More informationTestosterone Injection / Implant
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Testosterone Injection / Implant Page: 1 of 9 Last Review Date: December 5, 2014 Testosterone
More informationWhat Is the Low T Syndrome? Is Testosterone Supplementation Safe?
What Is the Low T Syndrome? Is Testosterone Supplementation Safe? UCSF Osher Mini Medical School March 7, 2018 Dolores Shoback, MD Staff Physician SF-VAMC Professor of Medicine, UCSF No disclosures or
More informationPART III: CONSUMER INFORMATION WARNINGS AND PRECAUTIONS. ANDROGEL Testosterone gel 1%
PART III: CONSUMER INFORMATION ANDROGEL Testosterone gel 1% This leaflet is part III of a three-part "Product Monograph" published when ANDROGEL was approved for sale in Canada and is designed specifically
More informationTestosterone (cypionate, enanthate, and propionate) powder, Fluoxymesterone powder, Methyltestosterone powder
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.08.37 Subject: Testosterone Powder Page: 1 of 11 Last Review Date: September 18, 2015 Testosterone powder
More informationTestosterone (cypionate, enanthate, and propionate) powder, Fluoxymesterone powder, Methyltestosterone powder
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.37 Subject: Testosterone Powder Page: 1 of 12 Last Review Date: November 30, 2018 Testosterone powder
More informationLow Testosterone Consultation Information
T Low Testosterone Consultation Information www.urologyaustin.com Andropause or Male Menopause This syndrome has been nicknamed ADAM, which stands for androgen deficiency of the aging male. It differs
More informationEAU GUIDELINES ON MALE HYPOGONADISM
EAU GUIDELINES ON MALE HYPOGONADISM (Text update March 2015) G.R. Dohle (Chair), S. Arver, C. Bettocchi, T.H. Jones, S. Kliesch, M. Punab Introduction Male hypogonadism is a clinical syndrome caused by
More informationGUIDELINES ON MALE HYPOGONADISM
GUIDELINES ON MALE HYPOGONADISM (Text update March 2015) G.R. Dohle (Chair), S. Arver, C. Bettocchi, T.H. Jones, S. Kliesch, M. Punab Introduction Male hypogonadism is a clinical syndrome caused by androgen
More informationTestosterone Injection and Implant
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.33 Subject: Testosterone Injection Implant Page: 1 of 10 Last Review Date: December 8, 2017 Testosterone
More informationTestosterone Injection and Implant
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.33 Subject: Testosterone Injection Implant Page: 1 of 10 Last Review Date: November 30, 2018 Testosterone
More informationTestosterone Injection and Implant
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.33 Subject: Testosterone Injection Implant Page: 1 of 10 Last Review Date: March 17, 2017 Testosterone
More informationTestosterone Treatment: Myths Vs Reality. Fadi Al-Khayer, M.D, F.A.C.E
Testosterone Treatment: Myths Vs Reality Fadi Al-Khayer, M.D, F.A.C.E The Biological Functions of Testosterone in Men Testosterone is essential to the musculoskeletal and metabolic systems throughout a
More informationConsent for Testosterone Therapy-Men Revised 4/10/18
Consent for Testosterone Therapy in Men You have been diagnosed with or have an increased risk of having a hormone deficiency and your provider has recommended treatment with bio-identical hormone replacement
More informationPharmacy Coverage Guidelines are subject to change as new information becomes available.
TESTOSTERONE REPLACEMENT THERAPY: ANDRODERM transdermal patch ANDROGEL pump transdermal gel and transdermal gel AXIRON transdermal solution FORTESTA transdermal gel NATESTO nasal gel STRIANT buccal mucoadhesive
More informationAndrogen deficiency. Dr Rakesh Iyer Staff Specialist in Endocrinology Calvary hospital
Androgen deficiency Dr Rakesh Iyer Staff Specialist in Endocrinology Calvary hospital Outline Pathological androgen deficiency - Background, causes, interpretation - Indications for treatment Androgen
More informationReference ID:
Medication Guide ANDROGEL (AN DROW JEL) CIII (testosterone gel) 1% Read this Medication Guide that comes with ANDROGEL 1% before you start taking it and each time you get a refill. There may be new information.
More informationISSM QUICK REFERENCE GUIDE ON TESTOSTERONE DEFICIENCY FOR MEN
International Society for Sexual Medicine - www.issm.info ISSM QUICK REFERENCE GUIDE ON TESTOSTERONE DEFICIENCY FOR MEN Version: September 2015 What is testosterone deficiency? Testosterone deficiency
More informationIndex. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Acquired hypogonadism, prevalence of, 165 167 primary, 165 secondary, 167 Adipose tissue, as an organ, 240 241 Adrenal hyperplasia, congenital,
More informationLate onset Hypogonadism. Dr KhooSay Chuan Department of Urology Penang General Hospital
Late onset Hypogonadism Dr KhooSay Chuan Department of Urology Penang General Hospital Late onset hypogonadism(loh) Definition LOH age associated testoteronedeficiency syndrome (TDS) Male menopause, andropause,
More informationEAU GUIDELINES ON MALE HYPOGONADISM
EAU GUIDELINES ON MALE HYPOGONADISM (Limited text update March 2017) G.R. Dohle (Chair), S. Arver, C. Bettocchi, T.H. Jones, S. Kliesch Introduction Male hypogonadism is a clinical syndrome caused by androgen
More informationTestosterone Oral Buccal Nasal. Android, Androxy, Methitest, Natesto, Striant, Testred. Description
1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.32 Subject: Testosterone Oral Buccal Nasal Page: 1 of 10 Last Review Date: June 24, 2016 Testosterone Oral Buccal Nasal Description
More informationTestosterone Oral Buccal Nasal. Android, Androxy, Methitest, Natesto, Striant, Testred. Description
1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.32 Subject: Testosterone Oral Buccal Nasal Page: 1 of 10 Last Review Date: March 17, 2017 Testosterone Oral Buccal Nasal Description
More informationPharmacy Coverage Guidelines are subject to change as new information becomes available.
TESTOSTERONE REPLACEMENT THERAPY: ANDRODERM transdermal patch ANDROGEL pump transdermal gel and transdermal gel ANDROID (methyltestosterone) oral capsule ANDROXY (fluoxymesterone) oral tablet AXIRON transdermal
More informationTestosterone Therapy in Men with Hypogonadism
Testosterone Therapy in Men with Hypogonadism (Endocrine Society 2018 Guideline) Ngwe Yin, MD Assistant Clinical Professor of Medicine, UCSF Fresno Medical Education Program Disclosures None Objective
More informationClinical Policy: Testosterone Pellet (Testopel) Reference Number: CP.CPA.## [Pre-P&T approval] Effective Date:
Clinical Policy: (Testopel) Reference Number: CP.CPA.## [Pre-P&T approval] Effective Date: 07.25.17 Last Review Date: 11.17 Line of Business: Commercial Coding Implications Revision Log See Important Reminder
More informationLate Onset Hypogonadism. Toh Charng Chee Hospital Selayang
Late Onset Hypogonadism Toh Charng Chee Hospital Selayang Introduction Although suppressed serum testosterone (T) is common in ageing men, only a small proportion of them develop the genuine syndrome of
More informationTestosterone Oral Buccal Nasal. Android, Androxy, Methitest, Natesto, Striant, Testred. Description
1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.32 Subject: Testosterone Oral Buccal Nasal Page: 1 of 10 Last Review Date: November 30, 2018 Testosterone Oral Buccal Nasal
More informationTESTOSTERONE REPLACEMENT THERAPY
TESTOSTERONE REPLACEMENT THERAPY Testosterone is the hormone responsible for the normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These include
More informationPoint-Counterpoint: Late Onset Hypogonadism (LOH)
Point-Counterpoint: Late Onset Hypogonadism (LOH) We are Under-diagnosing and Treating Men with LOH LOH is a Non-existent Disease ~ Robert E. Donohue, MD Late Onset Hypogonadism LOH: underdx. & undertx
More informationANDROGEN DEFICIENCY Update on Evaluation and Management
ANDROGEN DEFICIENCY Update on Evaluation and Management Kristen Gill Hairston, MD, MPH Associate Professor of Internal Medicine Section of Endocrinology and Metabolism Wake Forest University School of
More informationMEDICATION GUIDE Testosterone (tes-tos-te-rōn) Gel, CIII
MEDICATION GUIDE Testosterone (tes-tos-te-rōn) Gel, CIII Read this Medication Guide that comes with testosterone gel before you start using it and each time you get a refill. There may be new information.
More informationANDROGEL 50 mg, gel in sachet Testosterone
Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further
More informationHormone Therapy Overview for the Behavioral Health Provider. Julie Thompson, PA Fenway Health
Hormone Therapy Overview for the Behavioral Health Provider Julie Thompson, PA Fenway Health Continuing Medical Education Disclosure Program Faculty: Julie Thompson, PA Current Position: Physician s Assistant,
More informationHow to treat: TRT modalities and formulations
How to treat: TRT modalities and formulations Paul PIETTE, PharmD Senior Research Fellow Clinique Antoine Depage - Belgium ppiette@besins-healthcare.com Bruges 2014, May 15 th Testosterone-replacement
More informationMale New Patient Package
Male New Patient Package The contents of this package are your first step to restore your vitality. Please take time to read this carefully and answer all the questions as completely as possible. Thank
More informationLate onset hypogonadism
Late onset hypogonadism Farrukh Javid Male Menopause Clinical AND biochemical syndrome Testosterone levels decline by 0.4-3% per year after the age of 30, as opposed to the more rapid decline that occurs
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Testosterone Therapy Table of Contents Coverage Policy... 1 General Background... 6 Coding/Billing Information... 7 References... 7 Effective Date... 1/1/2018
More information5/7/2013. Patrick Nolan, DO, FACE
Patrick Nolan, DO, FACE Patient: T.W. 83 year old male 9/18/2012 AM sudden onset of Vertigo ER visit Had MRI, some labs Home on Zofran and medicines Complete resolution of sx after 2 days MRI chronic sinus
More informationANDROGEN DEFICIENCY A GUIDE TO MALE HORMONES A BOOKLET IN THE SERIES OF CONSUMER GUIDES ON MALE REPRODUCTIVE HEALTH FROM
ANDROGEN DEFICIENCY A GUIDE TO MALE HORMONES A BOOKLET IN THE SERIES OF CONSUMER GUIDES ON MALE REPRODUCTIVE HEALTH FROM First published in July 2003 by Andrology Australia 5th Edition, December 2015 Copyright
More informationManaging Testosterone Deficiency: A Practical Guide. John Grantmyre MD Professor of Urology Dalhousie University
Managing Testosterone Deficiency: A Practical Guide John Grantmyre MD Professor of Urology Dalhousie University 1 2 Case Study #1 A 59-Year-Old Man with Erectile Dysfunction 3 Case History Robert is a
More informationHormone Replacement Therapy For Men Consultation Information
Hormone Replacement Therapy For Men Consultation Information www.urologyaustin.com Biological Aging and Hormones As we age, a natural degeneration and aging of organs causes the levels of our hormones
More informationOVERVIEW OF PRESENTATION
Thanh D. Hoang, DO, FACP, FACE Division of Endocrinology Department of Internal Medicine WRNMMC 13 Aug 2018 OVERVIEW OF PRESENTATION Take Home Points Definition of Hypogonadism Clinical Manifestations
More informationINFORMED CONSENT FOR FEMINIZING HORMONE THERAPY
INFORMED CONSENT FOR FEMINIZING HORMONE THERAPY The use of hormone therapy for gender transition/affirmation is based on many years of experience treating trans persons. Research on hormone therapy is
More informationCorporate Medical Policy Testosterone Pellet Implantation for Androgen Deficiency
Corporate Medical Policy Testosterone Pellet Implantation for Androgen Deficiency File Name: Origination: Last CAP Review: Next CAP Review: Last Review: testosterone_pellet_implantation_for_androgen_deficiency
More informationOver the past decade, androgen replacement
J. Andrew Hoover, MD; Jeffrey T. Kirchner, DO, FAAFP Department of Family and Community Medicine, Lancaster General Hospital, Pa jhoover4@lghealth.org The authors reported no potential conflict of interest
More informationDefinition of Andropause
HORMONE REPLACEMENT THERAPY FOR MEN Thomas C. Reed R.Ph., F.A.C.A. Reed s Compounding Pharmacy 2729 E. Speedway 318-4421 reedsrx.com 7/7/2010 1 Definition of Andropause A gradual decline in sex hormone
More informationRecognizing and Managing Testosterone Deficiency
Recognizing and Managing Testosterone Deficiency J. Bruce Redmon, M.D. Professor Division of Endocrinology Departments of Medicine and Urologic Surgery Disclosure Information I have no financial relationships
More informationMale Patient Questionnaire & History
Male Patient Questionnaire & History Name: Today s Date: (Last) (First) (Middle) Date of Birth: Age: Weight: Occupation: Home Address: City: State: Zip: E-Mail Address: May we contact you via E-Mail? (
More informationPRISM Bruges June Herman Leliefeld Urologist. The Netherlands
PRISM Bruges 25-26 June 2015 Herman Leliefeld Urologist The Netherlands Guidelines EAU 2015: a rich source of Knowledge! Epidemiology/ Aetiology / Pathology Diagnostic evaluation Disease management Follow-Up
More informationA dro r gen e R e R p e lac a e c m e e m n e t t T her e a r p a y Androgen Replacement Therapy in the Aging O j b ecti t ve v s Male
Androgen Replacement Therapy in the Aging Male Thomas J. Walsh, MD, MS Department of Urology University of California, San Francisco Objectives 1. List 3 effects of androgens on normal male physiology.
More informationReproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands
Reproductive System Testes gametogenesis hormones Accessory reproductive organs Reproductive tract & Glands transport gametes provide nourishment for gametes Hormonal regulation in men Hypothalamus - puberty
More informationAVEED TESTOSTERONE INJECTION. Not an actual patient.
Ask your healthcare provider about LONG-ACTING AVEED AVEED TESTOSTERONE INJECTION 5 SHOTS A YEAR AFTER THE FIRST MONTH OF THERAPY Not an actual patient. AVEED is a prescription medicine that contains testosterone,
More informationState of California, California Health and Human Services Agency, Department of Managed Health Care 2013:
This policy has been developed through review of medical literature, consideration of medical necessity, generally accepted medical practice standards, and approved by the IEHP Pharmacy and Therapeutics
More informationThe Male Andropause. What are the symptoms? What are the risks of hormone deficiencies?
The Male Andropause By: Dr. Sangeeta Pati MD, FACOG Although, the male andropause has not been widely recognized, increased medical research has turned attention to the gradual hormone decline in males
More informationPrior Authorization Criteria Update: Androgens, Topical and Parenteral
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationMale Reproductive System
Male Hormone Issues The Ideal Male What describes a healthy male? Happy guy, well-muscled, good sex drive, focused brain This is what a guy can expect with the right level of testosterone Low testosterone?
More informationTestogel is used to replace the body s natural hormone testosterone when not enough is made by the body.
TESTOGEL testosterone Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Testogel. It does not contain all the available information. It does not take
More informationANDROGEN DEFICIENCY/MALE HYPOGONADISM
Medical Information to Support the Decisions of TUE Committees 1. Medical Condition Hypogonadism in men is a clinical syndrome that results from failure of the testes to produce physiological levels of
More informationHormones of brain-testicular axis
(Hormone Function) Hormones of brain-testicular axis anterior pituitary drives changes during puberty controlled by GnRH from hypothalamus begins to secrete FSH, LH LH targets interstitial endocrinocytes
More informationBenefits Investigation Form Instructions for Buy-and-Bill
Benefits Investigation Form Instructions for Buy-and-Bill Within this guide you can find: Step-by-step instructions on how to fill out the Benefits Investigation Form for Buy-and-Bill Key contact information
More informationEndocrine Update Mary T. Korytkowski MD Division of Endocrinology University of Pittsburgh
Endocrine Update 2016 Mary T. Korytkowski MD Division of Endocrinology University of Pittsburgh Disclosure of Financial Relationships Mary Korytkowski MD Honoraria British Medical Journal Diabetes Research
More informationPatient education for transgender feminizing hormone therapy
Date name DOB Patient education for transgender feminizing hormone therapy o Some transsexual, transgender, and gender non-conforming people choose to take hormone therapy to treat gender dysphoria and
More informationBenefits Investigation Form Instructions for Specialty Pharmacy
Benefits Investigation Form Instructions for Specialty Pharmacy Within this guide you can find: Step-by-step instructions on how to fill out the Benefits Investigation Form for Specialty Pharmacy Key contact
More informationContents. At A Glance 04. Male Hormones 06. Androgen Deficiency 10. Symptoms 11. Causes 14. Staying Healthy 20. Diagnosis 22. Treatment 29.
Androgen Deficiency Contents At A Glance 04 Male Hormones 06 Androgen Deficiency 10 Symptoms 11 - DATE REVIEWED: JANUARY 2019 (6TH EDITION) Healthy Male (Andrology Australia) 2003 Causes 14 Staying Healthy
More informationOne Day Hormone Check
One Day Hormone Check DOB: Sex: F MRN: Order Number: Completed: Received: Collected: Salivary Hormone Results Estradiol pmol/l >3330.0 Testosterone pmol/l
More informationHypogonadism in Men. CME Away India & Sri Lanka March 23 - April 7, 2018
Hypogonadism in Men CME Away India & Sri Lanka March 23 - April 7, 2018 Richard A. Bebb MD, ABIM, FRCPC Consultant Endocrinologist Medical Subspecialty Institute Cleveland Clinic Abu Dhabi Copyright 2017
More informationSexual dysfunction of chronic kidney disease. Razieh salehian.md psychiatrist
Sexual dysfunction of chronic kidney disease Razieh salehian.md psychiatrist Disturbances in sexual function are a common feature of chronic renal failure. Sexual dysfunction is inversely associated with
More informationWhere are the injections given? They are given in the upper outer hip.
1 How do you diagnose low Testosterone in men? Low Testosterone can be diagnosed if you have 3 or more of the following symptoms: lack of libido fatigue insomnia erectile dysfunction (ED) depression loss
More informationNatural Hormones Replacement An Evidence and Practice Based Approach
Natural Hormones Replacement An Evidence and Practice Based Approach Andres Ruiz, PharmD, MSc, FACA President/Partner Stonegate Pharmacy PRESENTED BY THE AMERICAN COLLEGE OF APOTHECARIES 2830 SUMMER OAKS
More informationWhy is my body not changing? Conflicts of interest. Overview 11/9/2015. None
Why is my body not changing? Murthy Korada Pediatrician, Pediatric Endocrinologist Ridge Meadows Hospital Surrey Memorial Hospital None Conflicts of interest Overview Overview of normal pubertal timing
More informationHormone Balance - Female Report SAMPLE. result graph based on Luteal Phase. result graph based on Luteal Phase
Patient Name: Patient DOB: Gender: Physician: Test Hormone Balance - Female Report SAMPLE Grote, Mary Jane Batch Number: B6437 2/16/1954 Accession Number: N52281 F Date Received: 2/3/2015 Any Lab Test
More informationTherapeutic Cohort Results
Patient: SAMPLE PATIENT DOB: Sex: MRN: Menopause Plus - Salivary Profile Therapeutic Cohort Results Hormone Average Result QUINTILE DISTRIBUTION 1st 2nd 3rd 4th 5th Therapeutic Range* Estradiol (E2) 8.7
More informationAsk your healthcare provider about AVEED TESTOSTERONE INJECTION 5 SHOTS A YEAR. Not an actual patient.
Ask your healthcare provider about LONG-ACTING AVEED AVEED TESTOSTERONE INJECTION 5 SHOTS A YEAR AFTER THE FIRST MONTH OF THERAPY Not an actual patient. CONSUMERS What is the most important information
More informationMen Getting Older Will Testosterone Keep Him Young?
Men Getting Older Will Testosterone Keep Him Young? Alvin M. Matsumoto, M.D. Associate Director, GRECC V.A. Puget Sound Health Care System Professor, Department of Medicine Division of Gerontology and
More informationImplantable Hormone Pellets
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationProf Dato Dr TAN Hui Meng University of Malaya, Kuala Lumpur University of Pennsylvania, USA
Prof Dato Dr TAN Hui Meng University of Malaya, Kuala Lumpur University of Pennsylvania, USA Prevailing context Increase number of men who are potential candidates for Testosterone Replacement Therapy
More informationElements for a Public Summary
VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Benign prostatic hyperplasia (BPH), also called benign prostatic hypertrophy or benign prostatic obstruction, is a condition in
More informationVancouver Neuropituitary Program
Step 4: Give the Injection 1. Clean the injection site skin with an alcohol swab; let it air dry. 2. Hold the skin around the injection site in the manner described above. 3. Insert the IM needle into
More informationTestosterone Therapy in Men An update
Testosterone Therapy in Men An update SANDEEP DHINDSA Associate Professor of Medicine Director, Division of Endocrinology and Metabolism, Saint Louis University, St. Louis, MO Presenter Disclosure None
More informationComparison of Testosterone Replacement Therapy Medications for Treatment of Hypogonadism
Brigham Young University BYU ScholarsArchive All Faculty Publications 2017-01-27 Comparison of Testosterone Replacement Therapy Medications for Treatment of Hypogonadism Karlen Beth Luthy Brigham Young
More informationPrescribing Framework for Testosterone in Adults
Prescribing Framework for Testosterone in Adults Patient s Name:.. NHS Number: Patient s Address:... (Use addressograph sticker) GP s Name:... Communication We agree to treat this patient within this Prescribing
More informationTherapeutic Cohort Results
Patient: JANE DOE DOB: December 31, 1968 Sex: F MRN: Order Number: Completed: February 26, 2016 Received: February 26, 2016 Collected: February 26, 2016 One Day Hormone Check - Salivary Profile Therapeutic
More information2. What you need to know before you use TESTOGEL
TESTOGEL 50 mg, gel in sachet Testosterone Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to
More informationTestim 1 Gel: Review of Clinical Data
European Urology Supplements European Urology Supplements 4 (2005) 24 30 Testim 1 Gel: Review of Clinical Data Tom A. McNicholas* Department of Urology, Lister Hospital, Corey s Mill Lane, Stevenage, Hertfordshire
More informationAdvisory Committee Industry Briefing Document. Testosterone Replacement Therapy
Advisory Committee Industry Briefing Document Testosterone Replacement Therapy Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting
More informationCurrent Data and Considerations Novel Testosterone Formulations
Current Data and Considerations Novel Testosterone Formulations 1 Hypogonadism: Treatment Safety and Prostate Health 2 Monitoring for Testosterone Therapy DRE 1,2 PSA Parameter Voiding/IPSS 1,2 Hemoglobin
More informationDidactic Series. Hypogonadism and HIV. Daniel Lee, MD UCSD Medical Center, Owen Clinic July 28, 2016
Didactic Series Hypogonadism and HIV Daniel Lee, MD UCSD Medical Center, Owen Clinic July 28, 2016 This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department
More informationWhat to Know a 21 st Century Approach to Transgender Medical Care
What to Know a 21 st Century Approach to Transgender Medical Care Joshua Safer, MD Transgender Medicine Research Group Center for Transgender Medicine and Surgery Patient / Mental Health Provider Gatekeeper
More informationHYPOGONADISM DEFINITION: PRODUCTION OF SEX HORMONES AND GERM CELLS IS INADEQUATE (ENDOCRINE SOCIETY)
HYPOGONADISM DEFINITION: PRODUCTION OF SEX HORMONES AND GERM CELLS IS INADEQUATE (ENDOCRINE SOCIETY) DEFECT OF THE REPRODUCTIVE SYSTEM THAT RESULTS IN LACK OF FUNCTION OF THE GONADS (Wikipedia) REDUCTION
More informationEarly or late childhood? Age driven. LH driven Start testosterone when LH begins to rise Indicates that the pituitary is trying and failing
Philip S. Zeitler MD. PhD Division of Endocrinology Children s Hospital Colorado Aurora, Colorado Primary testicular failure Central hormones responsible for onset of puberty are normal The testis itself
More information